Biocon Limited Issues Commercial Papers Worth ₹200 Crore

Biocon Limited has announced the issuance of Commercial Papers (CP) worth ₹200 Crore on a private placement basis. The issuance, which is proposed to be listed on the National Stock Exchange of India ...

Biocon Limited has announced the issuance of Commercial Papers (CP) worth ₹200 Crore on a private placement basis. The issuance, which is proposed to be listed on the National Stock Exchange of India Limited, has a tenure of 60 days. The allotment date for these Commercial Papers was January 02, 2026, with a maturity date of March 03, 2026. The coupon or interest offered is 6.80%, with the principal and interest payment scheduled for March 03, 2026. No charge or security has been created over the assets for this issuance. The Commercial Papers have been issued in favor of Kotak Mahindra Trustee Company Ltd, specifically for the Kotak Low Duration Fund and the Kotak Floating Rate Fund. The credit rating for these papers is IND A1+. This information is a continuation of a previous letter dated November 11, 2025, and will be available on the company's website.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Biocon Limited in the news today?

Biocon Limited (BIOCON) is in the news due to the issuance of commercial papers is a routine financing activity and does not inherently indicate positive or negative performance. the terms are standard for such instruments.

Debt FundraisingOther Regulatory Filings

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Biocon Limited Issues Commercial Papers Worth ₹200 Crore

January 2, 2026, 11:20 AM

AI Sentiment Analysis

Top Queries to Ask About Biocon Limited

More Details on This News

Biocon Limited has announced the issuance of Commercial Papers (CP) worth ₹200 Crore on a private placement basis. The issuance, which is proposed to be listed on the National Stock Exchange of India Limited, has a tenure of 60 days.

The allotment date for these Commercial Papers was January 02, 2026, with a maturity date of March 03, 2026. The coupon or interest offered is 6.80%, with the principal and interest payment scheduled for March 03, 2026. No charge or security has been created over the assets for this issuance.

The Commercial Papers have been issued in favor of Kotak Mahindra Trustee Company Ltd, specifically for the Kotak Low Duration Fund and the Kotak Floating Rate Fund. The credit rating for these papers is IND A1+. This information is a continuation of a previous letter dated November 11, 2025, and will be available on the company's website.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Biocon Limited

Discover more trending news on Prysm

View All